Clinical Trials on Varicella-zoster Virus in Italy

Total 954 results

San Luigi Gonzaga Hospital

Recruiting

Breathing Effort in Covid-19 Pneumonia: Effects of Positive Pressure, Inspired Oxygen Fraction and Decubitus

COVID-19 Pneumonia

Italy
Church & Dwight Company, Inc.
Evidilya S.r.l.

Recruiting

Two Seawater-based Formulations for Relief of Nasal Congestion in Paediatric Subjects

Nasal Congestion | Common Cold

Italy
Gruppo Oncologico del Nord-Ovest

Recruiting

Chemo-immunotherapy in Patients With Resectable Merkel Cell Carcinoma Prior to Surgery (MERCURY)

Merkel Cell Carcinoma

Italy
Università degli Studi dell'Insubria

Completed

Rapid Salivary Test to Detect SARS-CoV-2 (COVID-19)

COVID-19 | SARS-CoV 2 | Corona Virus Infection

Italy
Crucell Holland BV

Completed

A Study to Assess Immunogenicity Parameters After Vaccination Against Influenza and to Evaluate How These Parameters Change During the Influenza Season

Influenza

Italy
Fondazione IRCCS Policlinico San Matteo di Pavia

Not yet recruiting

Risk of Reactivation of Occult Hepatitis B in Cancer Patients During Immunotherapy.

Occult Hepatitis B Infection in Cancer Patients

Italy
Istituto Superiore di Sanità

Completed

Structured Treatment Interruptions in Chronic HIV Infection

HIV Infection

Italy
Fondazione Onlus Camillo De Lellis
Regione Abruzzo, Italy; Azienda Sanitaria Locale di Pescara

Unknown

Evaluation of the Safety and Efficacy of Standard Intravenous Immunoglobulins in Pregnant Women With Primary Cytomegalovirus Infection

Cytomegalovirus Congenital Infection

Italy
University of Pisa
University of Messina; University of Catania; Università degli Studi dell'Insubria

Not yet recruiting

A Randomized Clinical Trial to Evaluate the Effects of Atorvastatin on Graves' Orbitopathy (GO): the STAGO-2 Study (STAGO-2)

Graves' Orbitopathy

Italy
University of Pisa

Not yet recruiting

Sirolimus for Graves' Orbitopathy (GO) (SIRGO)

Graves Ophthalmopathy

Italy
Azienda Ospedaliero-Universitaria di Parma
University of Parma

Withdrawn

Phase II RCT to Assess Efficacy of Intravenous Administration of Oxytocin in Patients Affected by COVID-19 (OsCOVID19)

Covid-19 | SARS-CoV 2 | Corona Virus Infection

Italy, France
Istituto Auxologico Italiano

Recruiting

Dysphagia After Thyroidectomy (DYSPHATHYR)

Goiter | Thyroid Disease

Italy
Barbara Ensoli, MD, PhD

Suspended

Observational Study for the Evaluation of the Role of HIV-1 Tat Protein and Anti-Tat Immune Response In HIV Reservoir (ISS OBS T-005)

HIV/AIDS

Italy
Novartis
Novartis Vaccines

Completed

Safety and Immunogenicity of an Adjuvanted Influenza Vaccine in Subjects Aged 65 Years and Over.

Influenza

Italy
Novartis Vaccines

Completed

Safety and Immunogenicity of Two Adjuvanted and One Non-adjuvanted H5N1 Influenza Vaccine in Adults

Influenza

Italy
University of Pisa

Completed

Genetics and Epigenetics of Graves' Orbitopathy (GeneGO)

Graves Ophthalmopathy

Italy
Fondazione Policlinico Universitario Agostino Gemelli...

Completed

Cost-consequence Analysis of Influenza Vaccination in a Teaching Hospital in Rome

Influenza Vaccine | Cost-Benefit Analysis

Italy
University of Bologna

Unknown

Prevention of Transplant Atherosclerosis With Everolimus and Anti-cytomegalovirus Therapy (PROTECT)

Heart Transplantation | Cytomegalovirus Infection | Cardiac Allograft Vasculopathy

Italy
University Of Perugia

Completed

Influenza Vaccination and Oral Anticoagulant Therapy

Influenza Vaccines | Anticoagulants

Italy
Instituto Grifols, S.A.

Completed

Efficacy and Safety of Intramuscular HBIG Grifols for the Prevention of Recurrence After Liver Transplantation

Hepatitis B, Chronic

Italy
Crucell Holland BV

Completed

Immunogenicity and Safety of a Single 0.5 mL Dose of Inflexal V With a 0.25 mL 2-dose Regimen of Inflexal V

Influenza

Italy
Novartis Vaccines

Completed

Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2007/2008) When Administered to Elderly Subjects

Influenza

Italy
Novartis
Novartis Vaccines

Completed

Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2006/2007) When Administered to Subjects 18 Years of Age or Older

Influenza

Italy
Novartis
Novartis Vaccines

Completed

Safety and Immunogenicity of a Surface Antigen, Inactivated, Adjuvanted With MF59C.1, Seasonal Influenza Vaccine, Formulation 2009-2010

Seasonal Influenza

Italy
Novartis
Novartis Vaccines

Completed

Safety and Immunogenicity of a Inactivated Influenza Vaccine When Administered to Non Elderly Adults and Elderly Subjects.

Influenza Disease

Italy
Azienda Ospedaliero-Universitaria di Modena

Completed

Gonadal Function in Young to Middle Aged HIV-infected Men

Erectile Dysfunction | Human Immunodeficiency Virus | Hypogonadism, Male

Italy
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...
Universität Duisburg-Essen; Cultech Ltd, Port Talbot, UK; School of Medicine... and other collaborators

Unknown

Role of the Microbiome in Graves' Orbitopathy (Indigo)

Graves' Disease

Italy
Hoffmann-La Roche

Completed

A Study of Peginterferon Alfa-2a With or Without Ribavirin in Participants With Chronic Hepatitis D (CHD)

Hepatitis D, Chronic

Italy
AUSL Romagna Rimini

Terminated

Observational Study, Use of Canakinumab Administered Subcutaneously in the Treatment COVID-19 Pneumonia

COVID-19

Italy
University Of Perugia

Terminated

Colchicine in COVID-19: a Pilot Study (COLVID-19)

COVID-19

Italy
Neuromed IRCCS

Completed

ACE Inhibitors, Angiotensin II Type-I Receptor Blockers and Severity of COVID-19 (CODIV-ACE)

COVID-19

Italy
Centro di Riferimento Oncologico - Aviano

Unknown

Antiviral Therapy in Treating Patients With Slowly Progressing HIV-Related Kaposi's Sarcoma

Sarcoma

Italy
IRCCS San Raffaele
Hoffmann-La Roche; Abbott

Unknown

Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Antiretroviral (ARV) Naive Patients Starting Treatment With Anti-HCV Therapy

HIV Infections | Hepatitis C

Italy
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...

Recruiting

Effectiveness and Safety of Bulevirtide (BLV) Therapy in Patients With Chronic Hepatitis Delta (CHD) in Italy (D-SHIELD) (D-SHIELD)

Hepatitis D

Italy
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...

Completed

Efficacy and Safety of Bulevirtide (BLV) Therapy in HDV Chronic Hepatitis (CHD) in Italy (HEP4Di)

Hepatitis D

Italy
Novartis Vaccines

Completed

Safety and Immunogenicity of Surface Antigen, Inactivated, Adjuvanted With MF59C.1 Influenza Vaccine, Formulation 2008-2009

Interpandemic Influenza

Italy
Novartis Vaccines

Completed

Observational Safety and Effectiveness Study of Adjuvanted Swine Origin A (H1N1) Pandemic Subunit Egg Derived Vaccine

Influenza A (H1N1)

Italy
University of Pisa

Recruiting

A Conservative vs an Ablative Approach for Treatment of Hyperthyroidism in Patients With Graves' Orbitopathy (ABLAGO)

Graves' Orbitopathy

Italy
Azienda Ospedaliera di Padova
University of Padova; Regione Veneto

Completed

Different PEG-interferon and Ribavirin Schedules for Chronic Hepatitis C in the Real Clinical Practice.

Hepatitis C Virus | Chronic Liver Disease | Therapeutic Uses | Viral Hepatitis | Antiviral Agents

Italy
Fondazione Policlinico Universitario Agostino Gemelli...

Completed

Counter-Regulatory Hormonal and Stress Systems in Patients With COVID-19 (CROSS-CO19)

COVID-19

Italy
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...

Completed

Respiratory Physiotherapy in Severe COVID-19 Patients (FTR-COVID)

COVID-19

Italy
Azienda Socio Sanitaria Territoriale di Mantova

Completed

Convalescent Plasma in COVID-19 Elderly Patients (RESCUE)

COVID-19

Italy
IRCCS San Raffaele
Centro Cardiologico Monzino; Regione Lombardia; Orobix Srl; Microsoft Corporation; ASST Bergamo Est and other collaborators

Recruiting

Artificial Intelligence - SARS-CoV-2 Risk Evaluation (AI-SCoRE)

Covid19

Italy
Catherine Klersy
Fondazione IRCCS Policlinico San Matteo di Pavia

Active, not recruiting

Early Use of Hyperimmune Plasma in COVID-19 (COV-II-PLA)

Covid19

Italy
Federico II University

Completed

A Simplified Test to Assess Flavor in COVID-19 Patients

Covid19

Italy
ANNA FALANGA

Unknown

Hyperimmune Plasma for Patients With COVID-19 (IMMUNO-COVID19)

Covid19

Italy
University of Roma La Sapienza

Completed

Ribavirin Pre-treatment Followed by Combined Standard Therapy in Hepatitis C Virus (HCV) Recipients (RBV)

Hepatitis C

Italy
University of Roma La Sapienza
Istituto Superiore di Sanità

Unknown

Study of Recovery of Intestinal CD4+ and Th17 T Cells in HIV-infected Individuals on Short-term Antiretroviral Therapy

HIV Infection

Italy
University of Siena
Fondazione Policlinico Universitario Agostino Gemelli IRCCS; Istituti Ospitalieri... and other collaborators

Recruiting

Genetic Bases of COVID-19 Clinical Variability (GEN-COVID)

COVID-19

Italy
Fondazione Policlinico Universitario Agostino Gemelli...

Completed

A Specific miRNA Encoded by SARS-CoV-2 as a Diagnostic Tool to Predict Disease Severity in COVID-19 Patients (CoV-miR)

COVID-19

Italy

3

Subscribe